Resources
Resources
Events & News
12/01/2022. PicoImmune proudly announced its new services based on NanoString technology on Dec. 1, 2022. This will include NanoString nCounter for protein and gene expression analysis and GeoMX for spatial biology studies.
- 01/01/2022. NanoBiotec, LLC and PicoImmune Co. officially merged on Jan. 1, 2022. This will greatly strengthen our capabilities in the area of ultrasensitive and multiplex immunoassays and flow cytometric analyses for biomarkers and drug efficacy.
- 12/01/2021. Welcome to our new lab. NanoBiotec moved into a new space in Dec. 2021 to expand our biopharma services to our clients. Our new address is 622 Route-10, Suite 18, Whippany, NJ 07981.
- 12/01/2019. NanoBiotec is rated as one of the TOP PERFORMERS in 2019. This was independently rated by fast-growing biotechs using Science Exchange, the world’s leading R&D marketplace, based on RESPONSIVENESS, PRODUCTIVITY, AND POSITIVE CLIENT RECOMMENDATIONS. We are ranked as “#3 for various biomarker, functional and cell-based assays” (2019, Palo Alto, CA)
- 04/26/2018. We are presenting at the Frontier in Cancer Immunotherapy, The New York Academy of Sciences, April 26, 2018, WTC, New York
- 04/16/2017. We are presenting in the AACR 2017 Annual Meeting, April 16, 2017
Brochures
[wpforms id=”1959″ description = “true”]
ADCC and CDC Assay Brochure[wpforms id=”3726″ description = “true”]
ELISpot Assay Brochure[wpforms id=”1978″ description = “true”]
FirePlex Assay Brochure[wpforms id=”1954″ description = “true”]
Immune Checkpoint Blockade Assay Brochure[wpforms id=”3721″ description = “true”]
Immuno-Hemotoxicity Testing Brochure[wpforms id=”2280″ description = “true”]
Luminex Assay Brochure[wpforms id=”1974″ description = “true:]
Mixed Lymphocyte Reaction (MLR) Assay Brochure[wpforms id=”1964″ description = “true”]
Phagocytosis and Phagocyte Activation Assay Brochure[wpforms id=”1987″ description = “true”]
PhosphoFlow Assay Brochure[wpforms id=”1983″ description = “true”]
PrimeFlow Assay Brochure[wpforms id=”3486″ description = “true”]
QuantiGene Plex Assay Brochure[wpforms id=”2030″ description = “true”]
Rodent Inflammation Model Brochure[wpforms id=”3432″ description = “true”]
Targeted Protein Degrader (TPD) Discovery and DevelopmentPresentations
[wpforms id=”3512″ description = “true”]
PicoImmune Brief Intro 202303[wpforms id=”3422″ description = “true”]
Primary Human Mast Cell AssayLinks
Simple Western Antibody Database
R&D Systems Luminex Assay Customization
Procarta Immunoassay Customization
Milliplex Immunoassay CustomizationSample Submission Forms
IP & Confidentiality Policy
At PicoImmune, we understand that the protection of our clients’ IP and confidentiality is of the utmost importance. We stand by our emphasis on long-term collaborations and meet this challenge by providing comprehensive protective measures.Our strict IP and confidentiality policy is based upon:
- Preparing our teams with the correct mindset for quality IP protection through rigorous, repeated training.
- Preventing information leaks in all possible forms.
- Lab notebooks are strictly monitored, regulated, and filed.
- Ensuring employees’ legal compliance with company regulations.
- Signing a CDA with our clients
Terms & Conditions
At PicoImmune, we represent and warrant that all services shall be completed in a professional, workmanlike manner, with the degree of skill and care required by current, good, and sound professional procedures and practices. For more information, email us at hello@picoimmune.com